Recently, a team exploited a unique CAR construct by integrating Bcl-2 into CAR-T cells and found that this strategy could enhance CAR-T cells’ proliferation, thereby enhancing the anti-tumor activity in xenografted lymphoma mice and prolonging their lifespan. The gene discussed is BCL2; the disease is neoplasm.